Endometrial Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) [Phase 1, Phase 2]
Phase 1/2 trial investigating dual mTORC1/mTORC2 inhibitor with anastrozole for hormone receptor–positive endometrial carcinoma (metastatic)…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer [Phase 2]
Phase 2 study evaluating durvalumab with or without tremelimumab in endometrial cancer and carcinosarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of Folatescan (Technetium TC 99M EC20) in patients with suspected ovarian carcinom…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma [Phase 2]
Phase 2 trial evaluating TQB2858 injections combined with anlotinib hydrochloride in recurrent or metastatic advanced endometrial carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase Ib/II study evaluating MCS110 with PDR001 in advanced malignancies; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies [Phase 2]
Phase 2 clinical trial of selinexor (KPT-330) in female patients with advanced gynecologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus [Phase 2]
Phase IIa trial in endometrial carcinoma evaluating temsirolimus (POEM STUDY) has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery [NA]
Clinical trial update on lymph node mapping in newly diagnosed endometrial cancer patients undergoing surgery; the study is terminated with …
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Preoperative Olaparib Endometrial Carcinoma Study (POLEN)
Clinical trial update for preoperative olaparib in endometrial carcinoma; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma [Phase 2]
Phase II trial of nivolumab plus ipilimumab in non-resectable soft tissue and bone sarcomas, with exploration across several sarcoma subtype…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate [Phase 2]
Phase 2 study evaluating megestrol acetate for management of atypical endometrial hyperplasia and endometrial carcinoma. Results were posted…
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating lapatinib for recurrent or persistent endometrial cancer has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial update of ixabepilone in patients with recurrent or persistent endometrial cancer; completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluated temsirolimus in patients with metastatic or locally advanced recurrent endometrial cancer, with results p…
-
CLINICAL_TRIALS research · 2015-02-20Clinical Trial Update: Improved Method of Detecting Cancer Metastases [NA]
The document provides an update on a clinical trial investigating an improved method for detecting metastases in endometrial carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating thalidomide in patients with recurrent or persistent endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. [Phase 2]
Phase 2 trial evaluating fulvestrant for recurrent or metastatic endometrial carcinoma has completed with results posted in 2012.
-
CLINICAL_TRIALS research · 2011-01-10Clinical Trial Update: Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia
An update on a clinical trial investigating risk factors for concurrent endometrial carcinoma in patients with a curettage diagnosis of endo…